RxDoctor Payments Data

Tiffany Lau, MD

Physical Medicine & Rehabilitation · Lutz, FLNPI 1871027946

Payments from drug & device makers

$3,748in general payments, 2019–2025

Across 70 payments — averaging $53.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Nevro Corp.$206
  • Averitas Pharma Inc.$165
  • Pfizer$98
  • Amgen$70
  • AbbVie$60
  • plus $89 from 4 others

What the payments were for

  • Travel & lodging$2,09156%
  • Food & beverage$1,65744%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic46$3,061
Nevro Corp.4$206
Averitas Pharma Inc.7$165
Pfizer2$98
Amgen4$70
AbbVie3$60
Tonix Medicines, Inc.1$30
Vertex1$25
Protega Pharmaceutials Inc1$19
Convatec Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,748 in reported general payments places this provider in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$161,521
Medicare patients
329
Services billed
9,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen585$28,415
Xtampza ErOxycodone Myristate43$25,216
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen670$24,959
Fentanyl146$22,277
LinzessLinaclotide28$14,756
Oxycodone Hcl489$14,081
OxycontinOxycodone Hcl19$7,191
Pregabalin235$6,425
Morphine Sulfate ErMorphine Sulfate187$5,708
Gabapentin359$5,498
Hydromorphone Hcl195$4,711
Naloxone Hcl66$4,356
Tramadol Hcl245$3,095
Morphine Sulfate65$2,452
Cyclobenzaprine Hcl122$1,502

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$60$14,75628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.

Other physical medicine & rehabilitation in Lutz

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →